Your browser doesn't support javascript.
loading
Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies.
Mishra, Rahul; Elshimy, Ghada; Kannan, Lakshmi; Jacob, Aasems; Raj, Rishi.
Afiliação
  • Mishra R; Department of Hematology and Oncology, Cleveland Clinic Foundation, Cleveland, OH, United States.
  • Elshimy G; Department of Endocrinology, Diabetes, and Metabolism, Medical College of Georgia, Augusta University, Augusta, GA, United States.
  • Kannan L; Department of Nephrology, Pikeville Medical Center, Pikeville, KY, United States.
  • Jacob A; Department of Nephrology, Kentucky College of Osteopathic Medicine, University of Pikeville, Pikeville, KY, United States.
  • Raj R; Department of Hematology and Oncology, Pikeville Medical Center, Pikeville, KY, United States.
Front Endocrinol (Lausanne) ; 13: 983206, 2022.
Article em En | MEDLINE | ID: mdl-36034456

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cetoacidose Diabética / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cetoacidose Diabética / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article